Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Market Cap	1.12B -53.1%
Revenue (ttm)	4.99B -19.0%
Net Income	-4.23B
EPS	-4.87
Shares Out	1.12B
PE Ratio	n/a
Forward PE	27.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,109,500
Open	1.000
Previous Close	1.000
Day's Range	0.990 - 1.020
52-Week Range	0.530 - 3.770
Beta	1.18
Analysts	Sell
Price Target	1.90 (+90.0%)
Earnings Date	Nov 5, 2026

About BVMF:ONCO3

Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, oral chemotherapy, and prostate cancer hormone therapy; and surgery procedures, such as breast, head and neck, lung, prostate cancer, stomach, bladder ca...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2010
• Country: Brazil
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ONCO3

Financial Performance

In 2025, BVMF:ONCO3's revenue was 5.74 billion, a decrease of -7.83% compared to the previous year's 6.23 billion. Losses were -3.62 billion, 460.8% more than in 2024.

Analyst Summary

According to 4 analysts, the average rating for ONCO3 stock is "Sell." The 12-month stock price target is R$1.90, which is an increase of 90.00% from the latest price.

Price Target

R$1.90

(90.00% upside)

Analyst Consensus: Sell

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 7, 2026

Data Sources Report a data error